Landmark Radiation Therapy Treats Heart Condition in Canada

A pioneering procedure at the London Health Sciences Centre (LHSC) has successfully employed radiation therapy to treat a cardiac condition, marking a significant advancement in the management of heart rhythm disorders. George Westerik, the first patient to undergo this innovative treatment, received radiation therapy aimed at correcting his ventricular tachycardia, a condition characterized by rapid and irregular heartbeats. The six-minute session utilized a method known as stereotactic arrhythmia radioablation (STAR) at the Verspeeten Family Cancer Centre, effectively halting his arrhythmia without any adverse effects.

This groundbreaking case not only highlights LHSC’s commitment to advancing cardiac care but also reflects the ongoing collaboration between LHSC and Western University. The research program, which initiated this treatment, was supported by a generous donation of $1.35 million from the H2HCo Foundation to the Schulich School of Medicine & Dentistry. The introduction of STAR therapy represents a shift in how cardiac conditions can be approached, as it typically employs radiation techniques used in cancer treatment.

New Hope for Patients with Heart Rhythm Disorders

Ventricular tachycardia arises when damage to the heart leads to dangerously fast heart rhythms, potentially resulting in cardiac arrest. Traditional treatments often involve medication or invasive procedures, such as the implantation of a cardioverter defibrillator or catheter ablation. Yet, these methods do not work for all patients. Dr. Anthony Tang, a cardiologist and professor of medicine at Western, emphasizes that many patients struggle with their quality of life due to these heart conditions. He stated, “It’s hard for them to enjoy simple things like going for a walk because they don’t know when they will experience a dangerously fast heartbeat.”

The STAR technique offers a non-invasive alternative, targeting the specific areas of damaged heart tissue responsible for the abnormal rhythms. “Medications or ablations are all possible treatments, but they aren’t always effective and some patients aren’t eligible,” Dr. Tang noted. The hope is that this new approach will not only improve patient outcomes but potentially offer a cure for arrhythmias.

For Westerik, the procedure has already made a significant difference in his life. Reflecting on his experience, he shared, “I’d like to help my wife more around the house and play more with my grandkids.” This sentiment underscores the human impact of medical advancements and the importance of innovative treatments in restoring everyday activities for patients.

Future Directions in Cardiac Care

The successful application of radiation therapy for a cardiac condition at LHSC represents a major milestone in the integration of advanced treatment modalities. Dr. Belal Ahmad, a radiation oncologist and associate professor of oncology, expressed optimism about the treatment’s future. “Hearing the positive impact this treatment has had on George gives me hope that this could one day be part of the standard of care,” he stated.

With the initial procedure now complete, the LHSC team plans to continue evaluating the long-term effectiveness of STAR therapy. They aim to refine the technique to expand its availability to more patients in need of effective heart rhythm disorder treatments. The collaboration between LHSC and Western University showcases the potential of interdisciplinary research and innovation in developing new treatment paths for complex health issues.

The progress made in this case not only reflects a pivotal moment for cardiac care in Canada but also illustrates the broader implications of using radiation therapy beyond its traditional applications. As research continues, patients like George Westerik may benefit from treatments that enhance their quality of life and restore their ability to engage fully in daily activities.